Current pharmacological approaches to the treatment of T2DM are focused on enhancing insulin secretion, improving insulin sensitivity, or decreasing blood glucose levels by attenuating its renal re-absorption39,40. This evidence concerns the gene INS and type 2 diabetes mellitus.